scholarly article | Q13442814 |
P356 | DOI | 10.2174/1874467211205020255 |
P8608 | Fatcat ID | release_gsrmuyg2cfd7zhyybfgfcgv4s4 |
P698 | PubMed publication ID | 22122455 |
P2093 | author name string | Satyam Sarma | |
P433 | issue | 2 | |
P921 | main subject | heart failure | Q181754 |
P304 | page(s) | 255-263 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Current molecular pharmacology | Q26842459 |
P1476 | title | Use of clinically available PPAR agonists for heart failure; do the risks outweigh the potential benefits? | |
P478 | volume | 5 |
Q37739117 | A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease. |
Q49908591 | Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. |
Q26746998 | Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis |
Q36219006 | Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure. |
Search more.